Talk with Dublin BIC

I was invited by Dublin BIC to talk about Bonafi, patient safety, and falsified medicines. Our conversation sheds light on why it is important to know who your pharma customers and suppliers are, and how patients could be put at risk if the due diligence is not carried out. We also discussed the potential risks that have emerged as a result of COVID-19.